Differences of prediction performances by multigene assays in patients with breast cancer with distinct genetic backgrounds.

Fei Xing(Wake Forest University), Zhongyu Lu(Simcere Pharmaceutical (China)), Xuejiao Ma(China-Japan Friendship Hospital), Huimin Wang(Simcere Pharmaceutical (China)), Ran Ding(Simcere Pharmaceutical (China)), Ting‐Hao Chen(National Taiwan University)
Journal of Clinical Oncology
June 1, 2023
Cited by 0


Related Papers